enVVeno Medical (NVNO) Stock Statistics & Valuation Metrics

enVVeno Medical has a market cap or net worth of $93.73M. The enterprise value is $84.24M.

enVVeno Medical has 17,535,948 shares outstanding. The number of shares has decreased by -2.65% in one year.

enVVeno Medical’s return on equity (ROE) is -0.52 and return on invested capital (ROIC) is -55.12%.

The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.

In the last 12 months, enVVeno Medical had revenue of 0.00 and earned -21.82M in profits. Earnings per share was -1.27.

In the last 12 months, operating cash flow was -18.46M and capital expenditures 108.48K, giving a free cash flow of -18.35M billion.

enVVeno Medical pays an annual dividend of ―, resulting in a dividend yield of ―

enVVeno Medical upcoming earnings date is Nov 6, 2025, Before Open (Confirmed).

enVVeno Medical as a current ratio of 20.88, with Debt / Equity ratio of 2.67%

In the past 12 months, enVVeno Medical has paid 0.00 in taxes.

enVVeno Medical EV to EBITDA ratio is -2.40, with an EV/FCF ratio of -3.03.

enVVeno Medical has $35.14M in cash and marketable securities with $882.00K in debt, giving a net cash position of -$34.26M billion.

Gross margin is 34.11%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for enVVeno Medical is ―, which is 11.43% higher than the current price. The consensus rating is ―